Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 77
Filtrar
1.
Curr Drug Targets ; 24(2): 151-156, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-36366845

RESUMEN

Melanocortins are tiny protein molecules formed by the post-translational cleavage of proopiomelanocortin. These are bioactive peptides that are responsible for human and lower animal pigmentation patterns, energy homeostasis, and sexual function modulation. These peptides regulate numerous physiological functions by being generated in the central nervous system and peripheral tissues. Melanocortins elicit their varied biological effects by binding to a separate family of G protein, two primary proteolytic enzymes, proconvertases 1 and 2, according to recent research. These breakthroughs have opened up new avenues for research into the role of melanocortins, antagonists, and receptors in a number of physiological activities.


Asunto(s)
Receptores de Melanocortina , Animales , Humanos , Inflamación/metabolismo , Melanocortinas/metabolismo , Péptidos , Pigmentación , Receptores de Melanocortina/fisiología , Estrés Psicológico/metabolismo , Disfunciones Sexuales Fisiológicas/metabolismo , Masculino , Femenino , Cambios en el Peso Corporal
2.
J Endocrinol Invest ; 44(12): 2765-2776, 2021 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-34118018

RESUMEN

PURPOSE: To explore the effects of 6-month systemic testosterone (T) administration on clitoral color Doppler ultrasound (CDU) parameters in women with female sexual dysfunction (FSD). METHODS: 81 women with FSD were retrospectively recruited. Data on CDU parameters at baseline and after 6 months with four different treatments were available and thus further longitudinally analyzed: local non-hormonal moisturizers (NH group), n = 37; transdermal 2% T gel 300 mcg/day (T group), n = 23; local estrogens (E group), n = 12; combined therapy (T + E group), n = 9. Patients underwent physical, laboratory, and genital CDU examinations at both visits and completed different validated questionnaires, including the Female Sexual Function Index (FSFI). RESULTS: At 6-month visit, T therapy significantly increased clitoral artery peak systolic velocity (PSV) when compared to both NH (p < 0.0001) and E (p < 0.0001) groups. A similar increase was found in the T + E group (p = 0.039 vs. E). In addition, T treatment was associated with significantly higher FSFI desire, pain, arousal, lubrication, orgasm, and total scores at 6-month visit vs. baseline. Similar findings were observed in the T + E group. No significant differences in the variations of total and high-density lipoprotein-cholesterol, triglycerides, fasting glycemia, insulin and glycated hemoglobin levels were found among the four groups. No adverse events were observed. CONCLUSION: In women complaining for FSD, systemic T administration, either alone or combined with local estrogens, was associated with a positive effect on clitoral blood flow and a clinical improvement in sexual function, showing a good safety profile. TRIAL REGISTRATION NUMBER: NCT04336891; date of registration: April 7, 2020.


Asunto(s)
Clítoris , Estrógenos/administración & dosificación , Disfunciones Sexuales Fisiológicas , Testosterona/administración & dosificación , Ultrasonografía Doppler en Color/métodos , Administración Cutánea , Administración Tópica , Adulto , Clítoris/irrigación sanguínea , Clítoris/diagnóstico por imagen , Clítoris/fisiopatología , Estrógenos/efectos adversos , Femenino , Hormonas Gonadales/administración & dosificación , Hemodinámica/efectos de los fármacos , Humanos , Evaluación de Resultado en la Atención de Salud/métodos , Disfunciones Sexuales Fisiológicas/diagnóstico , Disfunciones Sexuales Fisiológicas/metabolismo , Disfunciones Sexuales Fisiológicas/fisiopatología , Disfunciones Sexuales Fisiológicas/terapia , Testosterona/efectos adversos , Resultado del Tratamiento
4.
J Alzheimers Dis ; 77(2): 821-830, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32741826

RESUMEN

BACKGROUND: Changes in sexual behaviors in frontotemporal dementia (FTD) are common and multifaceted, but not well characterized. OBJECTIVE: To characterize changes in sexual behaviors and intimacy in FTD compared to corticobasal syndrome (CBS) and normal controls (NC), and to evaluate the neuroanatomical associations of these changes. METHODS: Spouses of 30 FTD patients, 20 CBS patients, and 35 NC completed the Sexual Symptoms in Neurological Illness and Injury Questionnaire (SNIQ), which captures changes in sexual interest, inappropriate sexual behaviors, and prosocial sexual behaviors. 25 patients with FTD and 14 patients with CBS also received 18-flouorodeoxyglucose positron-emission topography (18FDG-PET) scans to determine the metabolic changes associated with these symptoms. RESULTS: FTD patients showed a greater increase in inappropriate sexual behaviors than CBS patients [p = 0.009] and NC [p < 0.001] and a greater decrease in prosocial sexual behaviors than CBS patients [p = 0.026] and NC [p < 0.001]. Groups did not differ in change in sexual interest. Among both patient groups, the most common change was decreased prosocial sexual behaviors p < 0.01. Hypometabolism in Brodmann's Area 10 (BA10), within the right frontal pole, correlated with decreased prosocial sexual behaviors [p(FWE-corr) <0.05, k = 44]. No anatomical associations were found with other sexual changes. CONCLUSION: Decreased prosocial sexual behavior was associated with hypometabolism in BA 10, an area tied to social knowledge and theory of mind, supporting the idea that changes reflect social-cognitive deficits due to frontal dysfunction.


Asunto(s)
Altruismo , Lóbulo Frontal/metabolismo , Demencia Frontotemporal/metabolismo , Conducta Sexual/fisiología , Disfunciones Sexuales Fisiológicas/metabolismo , Anciano , Femenino , Lóbulo Frontal/diagnóstico por imagen , Demencia Frontotemporal/diagnóstico por imagen , Demencia Frontotemporal/psicología , Humanos , Masculino , Persona de Mediana Edad , Tomografía de Emisión de Positrones/métodos , Conducta Sexual/psicología , Disfunciones Sexuales Fisiológicas/diagnóstico por imagen , Disfunciones Sexuales Fisiológicas/psicología , Conducta Social , Síndrome
5.
Clin Neurol Neurosurg ; 191: 105697, 2020 04.
Artículo en Inglés | MEDLINE | ID: mdl-32028129

RESUMEN

OBJECTIVES: Sexual dysfunctions [SDs] are common in women with epilepsy [WWE] but related studies were neglected in our locality. We aimed to determine the frequencies and severities of SDs and their clinical, hormonal and psychological determinants in WWE. PATIENTS AND METHODS: This study included 120 adults [mean age: 36.35 ± 2.89yrs] with temporal [63.33 %] and frontal [36.67 %] lobe epilepsies and treated with carbamazepine [CBZ] [n = 60] or oxcarbazepine [OXC] [n = 60] for mean duration of 18.63 ± 4.33yrs. Patients were assessed using Female Sexual Function Index [FSFI] questionnaire, Beck Depression Inventory [BDI-II] and Hamilton Anxiety Rating Scale [HAM-A]. Total testosterone, sex hormone binding globulin [SHBG] and free androgen index [FAI] were measured to assess endocrinal status. PATIENTS AND METHODS: This study included 120 adults [mean age: 36.35 ± 2.89yrs] with temporal [63.33 %] and frontal [36.67 %] lobe epilepsies and treated with carbamazepine [CBZ] [n = 60] or oxcarbazepine [OXC] [n = 60] for mean duration of 18.63 ± 4.33yrs. Patients were assessed using Female Sexual Function Index [FSFI] questionnaire, Beck Depression Inventory [BDI-II] and Hamilton Anxiety Rating Scale [HAM-A]. Total testosterone, sex hormone binding globulin [SHBG] and free androgen index [FAI] were measured to assess endocrinal status. RESULTS: The majority had occasional/rare frequency of seizures [76.67 %] and well controlled on antiepileptic drugs [AEDs] [81.67 %]. Compared to healthy women, WWE had lower total testosterone and FAI and higher SHBG levels. Compared to women on CBZ, those on OXC had lower frequency and well controlled seizures on medication [P = 0.0001 for both], higher testosterone [P = 0.01] and FAI [P = 0.001] and lower SHBG [P = 0.001] levels. Compared to controls, WWE had significantly higher frequencies and severities of SDs [total sexual function, desire, arousal, lubrication, orgasm, satisfaction and pain] and depression and anxiety symptoms. OXC therapy was associated with lower SDs [FSFI: P = 0.033] and anxiety symptoms [P = 0.025] compared to CBZ therapy. In multiple logistic regression analyses, determinants of SDs were the higher seizures frequency, increasing severities of depression and anxiety but not lower androgen levels or type of epilepsy or AEDs. CONCLUSIONS: Different aspects of SD and depression and anxiety symptoms were frequent in WWE. Determinants of SDs were the higher frequency of seizures and increasing severities of depression and anxiety. OXC had better control on seizures and thus lower frequencies and severities of SDs and depression and anxiety symptoms. Thus optimizing seizure control is important for psychological state and healthy sexual function in WWE.


Asunto(s)
Anticonvulsivantes/uso terapéutico , Ansiedad/psicología , Depresión/psicología , Epilepsia del Lóbulo Frontal/tratamiento farmacológico , Epilepsia del Lóbulo Temporal/tratamiento farmacológico , Disfunciones Sexuales Fisiológicas/fisiopatología , Adulto , Carbamazepina/uso terapéutico , Egipto , Epilepsia del Lóbulo Frontal/complicaciones , Epilepsia del Lóbulo Frontal/fisiopatología , Epilepsia del Lóbulo Frontal/psicología , Epilepsia del Lóbulo Temporal/complicaciones , Epilepsia del Lóbulo Temporal/fisiopatología , Epilepsia del Lóbulo Temporal/psicología , Femenino , Humanos , Persona de Mediana Edad , Oxcarbazepina/uso terapéutico , Globulina de Unión a Hormona Sexual/metabolismo , Disfunciones Sexuales Fisiológicas/complicaciones , Disfunciones Sexuales Fisiológicas/metabolismo , Disfunciones Sexuales Fisiológicas/psicología , Testosterona/metabolismo , Adulto Joven
6.
Asian J Androl ; 22(3): 265-273, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-31249270

RESUMEN

Low testosterone (T) is frequent in men with chronic illnesses. The clinical features of T deficiency (TD) overlap with those of chronic diseases. The aim of this study is to evaluate the relative contribution of chronic disease score (CDS) and low T to the presence of TD symptoms. A consecutive series of 3862 men (aged 52.1 ± 13.1 years) consulting for sexual dysfunction were studied. Several clinical and biochemical parameters were collected, including the structured interview, ANDROTEST, for the assessment of TD symptoms. Penile color Doppler ultrasound (PCDU) was also performed. Based on the medications taken, the CDS was calculated. For a subset of 1687 men, information on mortality was collected (follow-up of 4.3 ± 2.6 years). Higher CDS was associated with lower free and total T (TT) as well as with higher ANDROTEST score. When introducing CDS and TT in multivariable models adjusted for age, severe erectile dysfunction and impaired morning erections were associated with both CDS (odds ratio and 95% confidence interaval, OR [95% CI] = 1.25 [1.13; 1.37] and 1.38 [1.29; 1.48], respectively) and low TT (OR [95% CI] = 1.11 [1.00; 1.23] and 1.13 [1.06; 1.21], respectively). Similar results were obtained for PCDU parameters. Hypoactive sexual desire was associated with low TT (OR [95% CI] = 1.21 [1.13; 1.30]), whereas it was inversely related with CDS (OR [95% CI] = 0.91 [0.84; 0.97]). When considering mortality for major cardiovascular events, TT <8 nmol l-1, but not CDS, was a significant predictor (hazard ratio [95% CI] = 5.57 [1.51; 20.63]). Chronic illnesses are associated with an overt TD. Both chronic diseases and low T can be involved in determining symptoms present in subjects complaining for sexual dysfunction. This should be considered in the diagnostic workup for TD.


Asunto(s)
Enfermedades Cardiovasculares/epidemiología , Disfunción Eréctil/fisiopatología , Hipogonadismo/metabolismo , Libido , Afecciones Crónicas Múltiples/epidemiología , Testosterona/metabolismo , Adulto , Anciano , Trastornos Cerebrovasculares/epidemiología , Comorbilidad , Muerte Súbita Cardíaca/epidemiología , Disfunción Eréctil/epidemiología , Disfunción Eréctil/metabolismo , Humanos , Hipogonadismo/epidemiología , Italia/epidemiología , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Mortalidad , Isquemia Miocárdica/epidemiología , Pene/diagnóstico por imagen , Enfermedad Arterial Periférica/epidemiología , Modelos de Riesgos Proporcionales , Disfunciones Sexuales Fisiológicas/epidemiología , Disfunciones Sexuales Fisiológicas/metabolismo , Disfunciones Sexuales Fisiológicas/fisiopatología , Testosterona/deficiencia , Ultrasonografía Doppler en Color
7.
Neurosci Biobehav Rev ; 108: 1-23, 2020 01.
Artículo en Inglés | MEDLINE | ID: mdl-31647964

RESUMEN

Oxytocin (OT) subserves various physiological, behavioral, and cognitive processes. This paired with the ability to administer OT with minimal and inconsistent side effects has spurred research to explore its therapeutic potential. Findings from single-dose studies indicate that OT administration may be beneficial, at least under certain circumstances. The state of the field, however, is less clear regarding effects from chronic OT administration, which more closely resembles long-term treatment. To address this gap, this review synthesizes existing findings on the use of chronic OT administration in animal and human work. In addition to detailing the effects of chronic OT administration across different functional domains, this review highlights factors that have contributed to mixed findings. Based on this review, a basic framework of interrelated regulatory functions sensitive to chronic OT administration is offered. The paper also identifies future research directions across different contexts, populations, and outcomes, specifically calling for more systematic and standardized research on chronic OT administration in humans to supplement and expand what is currently known from preclinical work.


Asunto(s)
Ansiedad , Trastorno del Espectro Autista , Demencia , Inflamación , Oxitocina/administración & dosificación , Oxitocina/fisiología , Dolor , Esquizofrenia , Disfunciones Sexuales Fisiológicas , Trastornos por Estrés Postraumático , Estrés Psicológico , Trastornos Relacionados con Sustancias , Animales , Ansiedad/tratamiento farmacológico , Ansiedad/metabolismo , Trastorno del Espectro Autista/tratamiento farmacológico , Trastorno del Espectro Autista/metabolismo , Demencia/tratamiento farmacológico , Demencia/metabolismo , Humanos , Inflamación/tratamiento farmacológico , Inflamación/metabolismo , Dolor/tratamiento farmacológico , Dolor/metabolismo , Esquizofrenia/tratamiento farmacológico , Esquizofrenia/metabolismo , Disfunciones Sexuales Fisiológicas/tratamiento farmacológico , Disfunciones Sexuales Fisiológicas/metabolismo , Trastornos por Estrés Postraumático/tratamiento farmacológico , Trastornos por Estrés Postraumático/metabolismo , Estrés Psicológico/tratamiento farmacológico , Estrés Psicológico/metabolismo , Trastornos Relacionados con Sustancias/tratamiento farmacológico , Trastornos Relacionados con Sustancias/metabolismo
8.
Asian J Androl ; 22(3): 302-308, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-31274478

RESUMEN

Testicular volume (TV) is proposed to be a positive predictor of male fertility status, because of the relation known between the TV and the seminiferous tubule content. Independently of the measurement methodology, the role of TV and testicular ultrasound (US) assessments is still debated in andrological clinical practice. In this retrospective cohort study, we evaluated TV and testis US role in the diagnostic workup of andrological patients. All consecutive outpatients undergoing single-operator testis US (Modena, Italy) from March 2012 to March 2018 were enrolled, matching sonographic, hormonal, and seminal data. A total of 302 men were referred and evaluated for gynecomastia, suspected hypogonadism, couple infertility (CI), or sexual dysfunction. In the hypogonadal group, TV was lower compared to that in other groups (P < 0.001), and a significant, direct correlation between TV and testosterone level was observed in nonandrogen-treated patients (R = 0.911, P < 0.001), suggesting that testicular size could be related to the testosterone-secreting compartment. In the CI group, normozoospermic patients showed higher TV compared to men with impaired semen quality (P = 0.003) and azoospermia (P = 0.003). However, TV was not able to discriminate between patients presenting normal and altered semen quality. On the contrary, testis US inhomogeneity was more frequent in patients with impaired sperm quality (55.0%; P = 0.007) and azoospermia (40.0%; P = 0.012), compared to patients with normozoospermia (5%), identifying thereby the sonographic pattern as an informative parameter of the fertility status. Therefore, in the CI workup, US evaluation seems to be more informative than the TV assessment alone.


Asunto(s)
Azoospermia/diagnóstico por imagen , Hipogonadismo/diagnóstico por imagen , Infertilidad/diagnóstico por imagen , Análisis de Semen , Testículo/diagnóstico por imagen , Testosterona/metabolismo , Adulto , Azoospermia/metabolismo , Estudios de Cohortes , Ginecomastia/metabolismo , Humanos , Hipogonadismo/metabolismo , Infertilidad/metabolismo , Masculino , Persona de Mediana Edad , Tamaño de los Órganos , Estudios Retrospectivos , Disfunciones Sexuales Fisiológicas/diagnóstico por imagen , Disfunciones Sexuales Fisiológicas/metabolismo , Testículo/patología , Ultrasonografía
9.
Endocr J ; 67(1): 59-71, 2020 Jan 28.
Artículo en Inglés | MEDLINE | ID: mdl-31619592

RESUMEN

Little is known about type 1 diabetes mellitus (T1DM) impact on the male sexual and reproductive functions. We aim to evaluate the influence of T1DM on male sexual function, quality of sexual life, and sex hormone levels. A total of 57 male patients aged 18 to 50 years (mean = 33) with T1DM (duration mean = 15 years) had a medical examination and completed a set of questionnaires - International Index of Erectile Function-5 (IIEF-5), Beck Depression Inventory (BDI) and Sexual quality of life questionnaire male (SQoL-M). The prevalence of erectile dysfunction was 28.1% (IIEF-5 ≤21). Patients without diabetic nephropathy had better erectile function (p = 0.008). Subjects with better glycemic control (HbA1c <65 mmol/mol) had also better erectile function (p = 0.041). At least 8.8% patients had retrograde ejaculation. Blood serum levels of sex hormones were determined and compared to laboratory reference values of healthy men. Total testosterone level was not significantly changed, sex hormone binding globulin was higher (p < 0.001) and its level correlated with daily insulin dose adjusted to body weight (p = 0.008). Free androgen index and calculated free testosterone were lower (p = 0.013; p < 0.001), estradiol was not significantly changed, LH was higher (p < 0.001), FSH was unchanged, and prolactin was higher (p < 0.001). Prostate-specific antigen (PSA) negatively correlated with HbA1c (p < 0.001). To conclude, we found significant changes in sexual functions and sex hormone blood concentrations that indicate impairment of sexual and reproductive functions in T1DM males.


Asunto(s)
Diabetes Mellitus Tipo 1/epidemiología , Nefropatías Diabéticas/epidemiología , Disfunción Eréctil/epidemiología , Adulto , Depresión/epidemiología , Depresión/psicología , Diabetes Mellitus Tipo 1/complicaciones , Diabetes Mellitus Tipo 1/metabolismo , Nefropatías Diabéticas/etiología , Disfunción Eréctil/metabolismo , Disfunción Eréctil/psicología , Hemoglobina Glucada/metabolismo , Humanos , Hipoglucemiantes/uso terapéutico , Insulina/uso terapéutico , Masculino , Calidad de Vida , Globulina de Unión a Hormona Sexual/metabolismo , Disfunciones Sexuales Fisiológicas/epidemiología , Disfunciones Sexuales Fisiológicas/metabolismo , Disfunciones Sexuales Fisiológicas/psicología , Testosterona/metabolismo
10.
Clin Exp Pharmacol Physiol ; 47(5): 741-750, 2020 05.
Artículo en Inglés | MEDLINE | ID: mdl-31886562

RESUMEN

Opioids are pivotal therapeutics in the management of escalated chronic pain (moderate-severe). In the last two decades, the increased prescription rate and the prolonged usage of opioids shed light on opioid-induced endocrinopathy. Opioid-induced hypogonadism (OHG) results upon long-term opioid therapy. Clinically, patients with OHG are presented mainly by sexual dysfunction and infertility. Opioid clinical use in pain therapy is indispensable. However, the resultant sexual endocrinopathy cannot be overlooked and hence hormonal replacement therapy with regular monitoring of the patients represents a potential therapeutic strategy while avoiding opioids in patients with guaranteed long therapeutic exposure and switching to using low-dose naltrexone as alternative represents a possible prophylactic measure to ensure therapeutic compliance and secure a good life quality of patients.


Asunto(s)
Analgésicos Opioides/efectos adversos , Gónadas/efectos de los fármacos , Hipogonadismo/inducido químicamente , Infertilidad/inducido químicamente , Disfunciones Sexuales Fisiológicas/inducido químicamente , Analgésicos Opioides/administración & dosificación , Analgésicos Opioides/farmacocinética , Animales , Esquema de Medicación , Femenino , Fertilidad , Hormonas Esteroides Gonadales/metabolismo , Gónadas/metabolismo , Gónadas/fisiopatología , Terapia de Reemplazo de Hormonas , Humanos , Hipogonadismo/metabolismo , Hipogonadismo/fisiopatología , Hipogonadismo/prevención & control , Infertilidad/metabolismo , Infertilidad/fisiopatología , Infertilidad/prevención & control , Masculino , Naltrexona/administración & dosificación , Antagonistas de Narcóticos/administración & dosificación , Medición de Riesgo , Factores de Riesgo , Conducta Sexual/efectos de los fármacos , Disfunciones Sexuales Fisiológicas/metabolismo , Disfunciones Sexuales Fisiológicas/fisiopatología , Disfunciones Sexuales Fisiológicas/prevención & control , Factores de Tiempo
11.
J Clin Endocrinol Metab ; 104(10): 4660-4666, 2019 10 01.
Artículo en Inglés | MEDLINE | ID: mdl-31498871

RESUMEN

This Position Statement has been endorsed by the International Menopause Society, The Endocrine Society, The European Menopause and Andropause Society, The International Society for Sexual Medicine, The International Society for the Study of Women's Sexual Health, The North American Menopause Society, The Federacion Latinoamericana de Sociedades de Climaterio y Menopausia, The Royal College of Obstetricians and Gynecologists, The International Society of Endocrinology, The Endocrine Society of Australia, and The Royal Australian and New Zealand College of Obstetricians and Gynecologists.


Asunto(s)
Andrógenos/uso terapéutico , Disfunciones Sexuales Fisiológicas/tratamiento farmacológico , Disfunciones Sexuales Psicológicas/tratamiento farmacológico , Testosterona/uso terapéutico , Femenino , Humanos , Uso Fuera de lo Indicado , Posmenopausia , Premenopausia , Disfunciones Sexuales Fisiológicas/diagnóstico , Disfunciones Sexuales Fisiológicas/metabolismo , Disfunciones Sexuales Psicológicas/diagnóstico , Disfunciones Sexuales Psicológicas/metabolismo , Testosterona/metabolismo
12.
J Neurotrauma ; 36(24): 3378-3393, 2019 12 15.
Artículo en Inglés | MEDLINE | ID: mdl-31111794

RESUMEN

Spinal cord injury (SCI) causes sexual dysfunction, including anejaculation in men. Likewise, chronic mid-thoracic contusion injury impairs ejaculatory reflexes in male rats. Ejaculation is controlled by a spinal ejaculation generator (SEG) comprised of a population of lumbar spinothalamic (LSt) neurons. LSt neurons co-express four neuropeptides, including gastrin-releasing peptide (GRP) and galanin and control ejaculation via release of these peptides in lumbar and sacral autonomic and motor nuclei. Here, we tested the hypothesis that contusion injury causes a disruption of the neuropeptides that are expressed in LSt cell bodies and axon terminals, thereby causing ejaculatory dysfunction. Male Sprague Dawley rats received contusion or sham surgery at spinal levels T6-7. Five to six weeks later, animals were perfused and spinal cords were immunoprocessed for galanin and GRP. Results showed that numbers of cells immunoreactive for galanin were not altered by SCI, suggesting that LSt cells are not ablated by SCI. In contrast, GRP immunoreactivity was decreased in LSt cells following SCI, evidenced by fewer GRP and galanin/GRP dual labeled cells. However, SCI did not affect efferent connections of LSt, cells as axon terminals containing galanin or GRP in contact with autonomic cells were not reduced following SCI. Finally, no changes in testosterone plasma levels or androgen receptor expression were noted after SCI. In conclusion, chronic contusion injury decreased immunoreactivity for GRP in LSt cell soma, but did not affect LSt neurons per se or LSt connections within the SEG. Since GRP is essential for triggering ejaculation, such loss may contribute to ejaculatory dysfunction following SCI.


Asunto(s)
Eyaculación/fisiología , Péptido Liberador de Gastrina/metabolismo , Disfunciones Sexuales Fisiológicas/metabolismo , Traumatismos de la Médula Espinal/metabolismo , Animales , Enfermedad Crónica , Péptido Liberador de Gastrina/análisis , Locomoción/fisiología , Masculino , Ratas , Ratas Sprague-Dawley , Disfunciones Sexuales Fisiológicas/fisiopatología , Traumatismos de la Médula Espinal/fisiopatología , Vértebras Torácicas/lesiones
13.
Biomed Pharmacother ; 111: 1029-1035, 2019 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-30841416

RESUMEN

Sexual dysfunction is a side effect of the antidepressant drug paroxetine. Anogeissus leiocarpus is a medicinal plant with a wide range of biological activities which include antioxidant and antiulcer properties. With these in mind, we investigated the effect of Anogeissus leiocarpus stem bark extract on paroxetine-induced sexual dysfunction in male Wistar rats. Forty-two adult male Wistar rats were divided into seven experimental groups: normal control, PAR (10 mg/kg), PAR + sildenafil (5 mg/kg), ALE (50 and 100 mg/kg) and PAR + ALE (50 and 100 mg/kg). The experiment lasted for 21 days, after which the rats were subjected to sexual behavioral test. Various biochemical assays (phosphodiesterase-5, arginase, acetylcholinesterase, nitric oxide and MDA) were carried out on the penile tissue homogenate. From our findings, paroxetine significantly altered sexual behavior in male rats and increased phosphodiesterase-5, arginase and acetylcholinesterase activities with a concomitant decrease in nitric oxide level. Furthermore, paroxetine altered antioxidant status which revealed by increased MDA level and reduced thiol level. However, treatment with Anogeissus leiocarpus stem bark extract reversed the altered sexual behavior in male rats and boosted antioxidant status. In addition, administration of Anogeissus leiocarpus stem bark extract resulted in a significant attenuation of phosphodiesterase-5, arginase and acetylcholinesterase activities in paroxetine-induced rats. In view of the aforementioned findings, Anogeissus leiocarpus could be considered a promising natural agent in erectile dysfunction management.


Asunto(s)
Antioxidantes/metabolismo , Óxido Nítrico/metabolismo , Paroxetina/farmacología , Extractos Vegetales/farmacología , Plantas Medicinales/química , Conducta Sexual/efectos de los fármacos , Disfunciones Sexuales Fisiológicas/tratamiento farmacológico , Animales , Arginasa/metabolismo , Combretaceae/química , Fosfodiesterasas de Nucleótidos Cíclicos Tipo 5/metabolismo , Disfunción Eréctil/tratamiento farmacológico , Disfunción Eréctil/metabolismo , Masculino , Malondialdehído/metabolismo , Pene/efectos de los fármacos , Pene/metabolismo , Ratas , Ratas Wistar , Disfunciones Sexuales Fisiológicas/metabolismo , Citrato de Sildenafil/farmacología
14.
Neurol Sci ; 38(9): 1651-1655, 2017 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-28660561

RESUMEN

It is not a well-established finding in migraine that female sexual dysfunction (FSD) emerging as a natural course of disease, as a result of accompanying depression/anxiety, or an underlying endocrinological abnormality. Our aim is evaluating the relationship among frequency and severity of migraine, FSD, depression, anxiety, and related hormones in migrainous women. We examined 80 migrainous female and 62 controls cross sectionally. Beck Depression and Anxiety Inventories, Female Sexual Dysfunction Inventory, Migraine Disability Assessment Test, and hormonal analysis were done. Independent risk factors were identified by logistic regression analysis and cut-off values were measured with Receiver Operating Curve. FSD was not related to frequency or severity of migraine. Although depression and anxiety was related to arousal and lubrication, they had limited effect in FSD. There were correlations between prolactin (PRL), desire and lubrication, follicular-stimulating hormone FSH and orgasm, luteinizing hormone (LH), and pain. Also FSH-LH combination and PRL were found as independent factors for FSD. FSH-LH combination and PRL were found as independent factors which had effect on FSD in migraine. Our study is a precursor study about the effect of several hormones on FSD and migraine relationship. Hormonal effect on FSD in migraine will be clearer with future studies.


Asunto(s)
Hormonas/metabolismo , Trastornos Migrañosos/metabolismo , Disfunciones Sexuales Fisiológicas/metabolismo , Disfunciones Sexuales Psicológicas/metabolismo , Adolescente , Adulto , Estudios Transversales , Femenino , Humanos , Persona de Mediana Edad , Trastornos Migrañosos/complicaciones , Índice de Severidad de la Enfermedad , Disfunciones Sexuales Fisiológicas/complicaciones , Disfunciones Sexuales Psicológicas/complicaciones , Adulto Joven
15.
Cancer Res Treat ; 49(4): 1057-1064, 2017 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-28161937

RESUMEN

PURPOSE: Few studies have addressed gonadal and sexual dysfunctions in childhood cancer survivors. We evaluated the prevalence rates and risk factors for gonadal failure among adolescent/young adult childhood cancer survivors and their sexual function. MATERIALS AND METHODS: Subjects were childhood cancer survivors aged 15-29 years who had completed therapy more than 2 years ago. Demographic and medical characteristics were obtained from the patients' medical records. In addition, hormonal evaluation and semen analysis were performed and sexual function was evaluated via questionnaire. RESULTS: The study included 105 survivors (57 males, 48 females), of which 61 were adults (age > 19 years) and 44 were adolescents. In both males and females, the proportion of survivors with low sex hormone levels did not differ among age groups or follow-up period. Thirteen female subjects (27.1%) needed sex hormone replacement, while five males subjects (8.8%) were suspected of having hypogonadism, but none were receiving sex hormone replacement. Of 27 semen samples, 14 showed azospermia or oligospermia. The proportion of normospermia was lower in the high cyclophosphamide equivalent dose (CED) group (CED ≥ 8,000 mg/m2) than the low CED group (27.3% vs. 62.5%, p=0.047). Among adults, none were married and only 10 men (35.7%) and eight women (34.3%) were in a romantic relationship. Though a significant proportion (12.0% of males and 5.3% of females) of adolescent survivors had experienced sexual activity, 13.6% had not experienced sex education. CONCLUSION: The childhood cancer survivors in this study showed a high prevalence of gonadal/sexual dysfunction; accordingly, proper strategies are needed to manage these complications.


Asunto(s)
Supervivientes de Cáncer , Gónadas/fisiopatología , Neoplasias/complicaciones , Neoplasias/epidemiología , Disfunciones Sexuales Fisiológicas/epidemiología , Disfunciones Sexuales Fisiológicas/etiología , Adolescente , Adulto , Factores de Edad , Terapia Combinada/efectos adversos , Terapia Combinada/métodos , Femenino , Hormonas Esteroides Gonadales , Gónadas/metabolismo , Encuestas Epidemiológicas , Humanos , Masculino , Neoplasias/terapia , Prevalencia , Factores de Riesgo , Análisis de Semen , Conducta Sexual , Disfunciones Sexuales Fisiológicas/metabolismo , Adulto Joven
16.
J Integr Med ; 15(1): 64-76, 2017 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-28088261

RESUMEN

OBJECTIVE: The leaves of Parquetina nigrescens have been claimed in folk medicine to be useful for managing sexual dysfunction, but there is inadequate scientific evidence for this claim. This investigation was conducted to assess the effects of aqueous leaf extract of Parquetina nigrescens (AEPN) in rats induced with sexual dysfunction. METHODS: Male rats were allocated into various groups after being induced into sexual dysfunction with paroxetine hydrochloride. The groups were treated with distilled water, PowMaxM (reference drug), and the AEPN at 20, 40 and 80 mg/kg body weight (BW) respectively for 7 d. Frequencies of mount (MF), intromission (IF), ejaculation (EF), as well as latencies of mount (ML), intromission (IL) and post-ejaculatory interval (PEI) were progressively monitored with receptive female rats on days 1, 3 and 7. The precentage of mounted, intromitted, and ejaculated rats, intromission ratio (IR), copulatory efficiency (CE) and intercopulatory interval (ICI) were also computed. Standard methods were employed to determine the levels of serum luteinizing and follicle stimulating hormones (LH and FSH), testosterone, nitric oxide (NO) and the activity of phosphodiesterase V (PDE5). RESULTS: The plant contained alkaloids, saponins, flavonoids, cardiac glycosides, steroids, tannins, phlobatannins, cardenolides, phenolics, anthraquinones and triterpenes with alkaloids (2.32 mg/g) occurring in greatest quantity while flavonoids, anthraquinones and cardenolides (0.01 mg/g, each) were the least. All the 20 standard amino acids were detected in the plant leaf, with the lowest concentration being 0.30 mg/g for methionine and the highest being 2.12 mg/g for cysteine. Furthermore, P. nigrescens leaves contained Na, K, Fe, Mg, Zn, Ca, Cu, Mn, P, Pb, Cd, Ni, Cr, and Co, with Fe present in the highest and Co the lowest concentrations. Paroxetine significantly (P<0.05) reduced MF, IF, EF, percentage mounted , intromitted, ejaculated, IR, CE, serum testosterone, LH, FSH and NO, while ML, IL, PEI, IF and PDE5 were significantly (P<0.05) increased and/or prolonged. The AEPN significantly reversed these paroxetine-treatment-related alterations with most profound activity at the highest dose of 80 mg/kg BW, similar to that of the PowMaxM-treated animals. CONCLUSION: The AEPN restored both the physical and biochemical indices of male sexual activity/competence via changes in reproductive hormones, NO and PDE5 activity. The pro-sexual activity, attributed to a myriad of mineral, amino acid and secondary metabolite constituents, was best at 80 mg/kg BW of AEPN.


Asunto(s)
Apocynaceae/química , Fitoquímicos/uso terapéutico , Fitoterapia , Extractos Vegetales/uso terapéutico , Conducta Sexual Animal/efectos de los fármacos , Disfunciones Sexuales Fisiológicas/tratamiento farmacológico , Animales , Copulación/efectos de los fármacos , Fosfodiesterasas de Nucleótidos Cíclicos Tipo 5/metabolismo , Eyaculación/efectos de los fármacos , Femenino , Hormona Folículo Estimulante/sangre , Hormona Luteinizante/sangre , Masculino , Óxido Nítrico/sangre , Fitoquímicos/análisis , Fitoquímicos/farmacología , Extractos Vegetales/química , Extractos Vegetales/farmacología , Hojas de la Planta/química , Ratas Wistar , Disfunciones Sexuales Fisiológicas/metabolismo , Disfunciones Sexuales Fisiológicas/fisiopatología , Testosterona/sangre
17.
Eur Cytokine Netw ; 28(4): 141-150, 2017 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-29478964

RESUMEN

Infertility, which increased worldwide over the past few decades, has recently been linked to obesity prevalence. Adipokines, produced by adipose tissue, could be the link between obesity and infertility. The association between circulating adipokines and female infertility has been extensively studied in the last ten years. However, the male aspect has been less investigated, although some adipokines are present in seminal plasma. We have attempted to analyze published studies that measured seminal plasma adipokines and their relationships with semen parameters. Apart from leptin, other seminal adipokines have rarely been studied. Indeed, leptin seems to have a differential role depending on its concentration in the seminal plasma. Thus, it could have a beneficial effect at lower concentrations but a deleterious effect at higher seminal levels. Although some studies are currently available, the roles of leptin and other adipokines in seminal plasma on sperm parameters and their consequences on male fertility remain to be clarified.


Asunto(s)
Adipoquinas/metabolismo , Reproducción/fisiología , Semen/metabolismo , Acrosoma/metabolismo , Animales , Fragmentación del ADN , Susceptibilidad a Enfermedades , Humanos , Masculino , Potencial de la Membrana Mitocondrial , Enfermedades Metabólicas/etiología , Enfermedades Metabólicas/metabolismo , Enfermedades Metabólicas/fisiopatología , Obesidad/etiología , Obesidad/metabolismo , Obesidad/fisiopatología , Especies Reactivas de Oxígeno/metabolismo , Disfunciones Sexuales Fisiológicas/etiología , Disfunciones Sexuales Fisiológicas/metabolismo , Recuento de Espermatozoides , Motilidad Espermática , Espermatozoides/metabolismo , Espermatozoides/patología
18.
J Tradit Chin Med ; 36(3): 347-52, 2016 Jun.
Artículo en Chino | MEDLINE | ID: mdl-27468550

RESUMEN

RESULTS: There was a decrease in accessory genital organ weight, plasma testosterone, and sexual behavior, as well as a low number of c-Fos-positive cells and a large nNOS-positive cell area in orchidectomized rats. Administration of the herbal medicine increased accessory genital organ weight, testosterone level, mating behavior, and c-Fos-positive cell number, while it decreased the nNOS-positive cell area in orchidectomized rats. CONCLUSION: An increase of plasma testosterone after administration of "kidney-nourishing" herbal medicine might contribute to the elevated sexual function and activity in orchidectomized rats. In addition, a central nervous system mechanism, such as the functional alteration of NAc, might be involved. Abstract OBJECTIVE: To determine whether the central nervous system is involved in the effect of Chinese herbal medicine on sexual function recovery in orchidectomized rats. METHODS: Orchidectomized rats were administered intragastrically with a decoction of "kidney-nourishing" Chinese herbal medicine once per day for 28 days. Accessory genital organ weight, plasma testosterone, and mating behavior were investigated. The expression of c-Fos and neuronal nitric oxide synthase (nNOS) in neuronal cells in the nucleus accumbens (NAc) was analyzed by immunohistochemistry.


Asunto(s)
Medicamentos Herbarios Chinos/administración & dosificación , Óxido Nítrico Sintasa de Tipo I/genética , Núcleo Accumbens/efectos de los fármacos , Proteínas Proto-Oncogénicas c-fos/genética , Disfunciones Sexuales Fisiológicas/tratamiento farmacológico , Animales , Femenino , Humanos , Masculino , Óxido Nítrico Sintasa de Tipo I/metabolismo , Núcleo Accumbens/metabolismo , Orquiectomía , Proteínas Proto-Oncogénicas c-fos/metabolismo , Ratas , Conducta Sexual , Disfunciones Sexuales Fisiológicas/genética , Disfunciones Sexuales Fisiológicas/metabolismo , Disfunciones Sexuales Fisiológicas/fisiopatología , Testosterona/metabolismo
19.
Curr Drug Metab ; 17(6): 573-81, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27000076

RESUMEN

BACKGROUND: Valproic acid (VPA) is a broad spectrum antiepileptic drug (AED) that is generally regarded as a first-choice agent for most forms of idiopathic and symptomatic generalised epilepsies. Available data suggest that menstrual disorders and certain endocrine manifestations of reproductive system disorders may be more common in women treated with VPA than in those treated with other AEDs. METHODS: A PubMed search for MEDLINE was undertaken to look for studies using the terms "VPA metabolism", "VPA and sexual functions in men", "VPA and sexual functions in women" and "VPA metabolism and endocrine disorders" as key words. The period covered was approximately 20 years. RESULTS: In women, VPA medication is associated with hyperandrogenism, polycystic ovary/polycystic ovarian syndrome, menstrual disorders and ovulatory failure. Men on VPA therapy show abnormalities in androgens blood levels, sperm motility and erectile dysfunctions. VPA negatively affects the release of luteinizing hormone, follicle stimulating hormone and prolactin but also the drug interferes in peripheral endocrine hormones. Its broad inhibitory action on cytochrome and glucuronidation systems can lead to high serum concentration of testosterone, androstenedione and dehydroepiandrosterone sulfate. VPA-dependent obesity and hyperinsulinemia can further contribute to an increase in sexual dysfunctions. CONCLUSIONS: VPA interferes with the endocrine system at multiples levels causing several reproductive and sexual dysfunctions in women and men with epilepsy, especially when administered in pubertal age. Since VPA is a first line AED both in children and adult with epilepsy and long-term medication with this drug is sometimes necessary, it is very important for physicians to implement strict monitoring of patients taking VPA in order to identify these kinds of side effects at an early stage.


Asunto(s)
Anticonvulsivantes/efectos adversos , Enfermedades del Sistema Endocrino/inducido químicamente , Sistema Endocrino/efectos de los fármacos , Reproducción/efectos de los fármacos , Conducta Sexual/efectos de los fármacos , Disfunciones Sexuales Fisiológicas/inducido químicamente , Ácido Valproico/efectos adversos , Animales , Anticonvulsivantes/farmacocinética , Biotransformación , Sistema Endocrino/metabolismo , Sistema Endocrino/fisiopatología , Enfermedades del Sistema Endocrino/metabolismo , Enfermedades del Sistema Endocrino/fisiopatología , Femenino , Humanos , Masculino , Factores de Riesgo , Disfunciones Sexuales Fisiológicas/metabolismo , Disfunciones Sexuales Fisiológicas/fisiopatología , Ácido Valproico/farmacocinética
20.
J Ethnopharmacol ; 175: 181-4, 2015 Dec 04.
Artículo en Inglés | MEDLINE | ID: mdl-26368291

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: Aqueous root extract of Lecaniodiscus cupanioides is widely used in the management of sexual dysfunction in Nigeria. The effect of aqueous root extract of L. cupanioides root on the concentrations of penile cyclic Guanosine Monophosphate (cGMP) and plasma nitric oxide in paroxetine-induced sexually impaired male rats was evaluated. METHODS: Thirty (30) albino rats were assigned into six groups (A, B, C, D, E and F) of five rats each such that animals in Group A (control) received distilled water while those in Groups B, C, D, E and F which were induced into sexual dysfunction (p.o 10mg/kg of paroxetine hydrochloride suspension in Tween-80) and in addition received distilled water, 7.14 mg/kg body weight of a reference herbal drug (PowmaxM), 25, 50 and 100mg/kg body weight of the extract respectively, orally, once daily for five days. RESULTS: Administration of paroxetine significantly reduced the levels of penile cyclic Guanosine Monophosphate (cGMP) and plasma nitric oxide. These decreases were dose dependently reversed by the aqueous extract of L. cupanioides root. The reversal by the 25 and 50mg/kg body weight of the extract compared favorably with the PowmaxM, whereas the 100mg/kg body weight of the extract compared favorably with the non-sexually impaired distilled water treated control animals. CONCLUSION: The results of this study show that aqueous extract of L. cupanioides root restored the levels of cGMP and nitric oxide in sexually impaired rats. This study further lends credence to the use of aqueous root extract of L. cupanioides in the management of sexual dysfunction in Nigeria.


Asunto(s)
Extractos Vegetales/farmacología , Sapindaceae , Disfunciones Sexuales Fisiológicas/metabolismo , Animales , GMP Cíclico/metabolismo , Masculino , Óxido Nítrico/sangre , Pene/efectos de los fármacos , Pene/metabolismo , Raíces de Plantas , Ratas Wistar , Disfunciones Sexuales Fisiológicas/sangre , Transducción de Señal/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA